BACE1 mRNA expression in Alzheimer's disease postmortem brain tissue

Journal of Alzheimer's Disease

Volumn 22, Issue 4, 2010, Pages 1111-1122

  Coulson, David T R ^a   Beyer, Nancy ^a   Quinn, Joe G ^a   Brockbank, Simon ^a   Hellemans, Jan ^b   Irvine, G Brent ^a   Ravid, Rivka ^c,d   Johnston, Janet A ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

^c Brain Bank Consultants   (Netherlands)

^d NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

Author keywords

Amyloid protein precursor; Braak staging; gene expression; Lewy body disease; Parkinson's disease; protease; qPCR; reference gene; reverse transcriptase polymerase chain reaction

Indexed keywords

BETA SECRETASE 1; GLIAL FIBRILLARY ACIDIC PROTEIN; MESSENGER RNA; NEURON SPECIFIC ENOLASE;

ALZHEIMER DISEASE; ARTICLE; BRAIN REGION; CADAVER; CELL POPULATION; CONTROLLED STUDY; DEGENERATIVE DISEASE; DIFFUSE LEWY BODY DISEASE; DISEASE COURSE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MIDDLE TEMPORAL GYRUS; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SUPERIOR FRONTAL GYRUS; SUPERIOR PARIETAL LOBULE; VALIDATION PROCESS;

EID: 78650233443     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2010-101254     Document Type: Article

References (40)

1. Vassar R, Bennett BD, Babu-Khan S, Kahn S, Mendiaz EA, Denis P, Teplow DB, Ross S, Amarante P, Loeloff R, Luo Y, Fisher S, Fuller J, Edenson S, Lile J, Jarosinski MA, Biere AL, Curran E, Burgess T, Louis JC, Collins F, Treanor J, Rogers G, Citron M (1999) Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science 286, 735-741.
2. Sinha S, Anderson JP, Barbour R, Basi GS, Caccavello R, Davis D, Doan M, Dovey HF, Frigon N, Hong J, Jacobson-Croak K, Jewett N, Keim P, Knops J, Lieberburg I, Power M, Tan H, Tatsuno G, Tung J, Schenk D, Seubert P, Suomensaari SM, Wang S, Walker D, John V (1999) Purification andcloning of amyloid precursor protein beta-secretase from human brain. Nature 402, 537-540.
3. Farzan M, Schnitzler CE, Vasilieva N, Leung D, Choe H (2000) BACE2, a beta -secretase homolog, cleaves at the beta site and within the amyloid-beta region of the amyloid-beta precursor protein. Proc Natl Acad Sci U S A 97, 9712-9717. (Pubitemid 30650841)
4. Johnston JA, Liu WW, Todd SA, Coulson DT, Murphy S, Irvine GB, Passmore AP (2005) Expression and activity of beta-site amyloid precursor protein cleaving enzyme in Alzheimer's disease. Biochem Soc Trans 33, 1096-1100. (Pubitemid 41659122)
5. Stockley JH, O'Neill C (2007) The proteins BACE1 and BACE2 and beta-secretase activity in normal and Alzheimer's disease brain. Biochem Soc Trans 35, 574-576. (Pubitemid 46975079)
6. Willem M, Lammich S, Haass C (2009) Function, regulation and therapeutic properties of beta-secretase (BACE1). Semin Cell Dev Biol 20, 175-182.
7. Miners JS, van Helmond Z, Kehoe PG, Love S (2010) Changes with Age in the Activities of beta-secretase and the Abeta-degrading Enzymes Neprilysin, Insulin-degrading Enzyme and Angiotensin-converting Enzyme. Brain Pathol 20, 794-802.
8. Zhao J, Fu Y, Yasvoina M, Shao P, Hitt B, O'Connor T, Logan S, Maus E, Citron M, Berry R, Binder L, Vassar R (2007) Beta-site amyloid precursor protein cleaving enzyme 1 levels become elevated in neurons around amyloid plaques: implications for Alzheimer's disease pathogenesis. J Neurosci 27, 3639-3649. (Pubitemid 46557686)
9. Holsinger RM, McLean CA, Beyreuther K, Masters CL, Evin G (2002) Increased expression of the amyloid precursor beta-secretase in Alzheimer's disease. Ann Neurol 51, 783-786. (Pubitemid 34568861)
10. Yasojima K, McGeer EG, McGeer PL (2001) Relationship between beta amyloid peptide generating molecules and neprilysin in Alzheimer disease and normal brain. Brain Res 919, 115-121. (Pubitemid 33016594)
11. Preece P,Virley DJ, Costandi M,Coombes R, Moss SJ, Mudge AW, Jazin E, Cairns NJ (2003) Beta-secretase (BACE) and GSK-3 mRNA levels in Alzheimer's disease. Brain Res Mol Brain Res 116, 155-158. (Pubitemid 36993706)
12. Matsui T, Ingelsson M, Fukumoto H, Ramasamy K, Kowa H, Frosch MP, Irizarry MC, Hyman BT (2007) Expression of AβPP pathway mRNAs and proteins in Alzheimer's disease. Brain Res 1161, 116-123. (Pubitemid 47068429)
13. Li R, Lindholm K, Yang LB, Yue X, Citron M, Yan R, Beach T, Sue L, Sabbagh M, Cai H, Wong P, Price D, Shen Y (2004) Amyloid beta peptide load is correlated with increased beta-secretase activity in sporadic Alzheimer's disease patients. Proc Natl Acad Sci U S A 101, 3632-3637. (Pubitemid 38338246)
14. Bustin SA (2002) Quantification of mRNA using real-time reverse transcription PCR (RT-PCR): trends and problems. J Mol Endocrinol 29, 23-39. (Pubitemid 34965744)
15. Suzuki T, Higgins PJ, Crawford DR (2000) Control selection for RNA quantitation. BioTechniques 29, 332-337. (Pubitemid 30658285)
16. Huggett J, Dheda K, Bustin S, Zumla A (2005) Real-time RT-PCR normalisation; strategies and considerations. Genes Immun 6, 279-284. (Pubitemid 40903399)
17. Coulson DTR, Brockbank S, Quinn JG, Murphy S, Ravid R, Irvine GB, Johnston JA (2008) Validation of housekeeping genes for the normalization of qPCR gene expression studies in human brain tissue. BMC Mol Biol 9, 46.
18. Braak H, Braak E, Bohl J (1993) Staging of Alzheimer-related cortical destruction. Eur Neurol 33, 403-408. (Pubitemid 23358066)
19. Ravid R, Van Zwieten EJ, Swaab DF (1992) Brain banking and the human hypothalamus - factors to match for, pitfalls and potentials. Prog Brain Res 93, 83-95. (Pubitemid 23008658)
20. Ravid R (2008) Standard Operating Procedures, ethical and legal regulations in BTB (Brain/Tissue/Bio) banking: what is still missing? Cell Tissue Bank 9, 121-137.
21. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34, 939-944. (Pubitemid 14076461)
22. Harrison PJ, Heath PR, Eastwood SL, Burnet PW, McDonald B, Pearson RC (1995) The relative importance of premortem acidosis and postmortem interval for human braingene expression studies: selective mRNA vulnerability and comparison with their encoded proteins. Neurosci Lett 200, 151-154.
23. Preece P, Cairns NJ (2003) Quantifying mRNA in postmortem human brain: influence of gender, age at death, postmortem interval, brain pH, agonal state and inter-lobe mRNA variance. Brain Res Mol Brain Res 118, 60-71. (Pubitemid 37238988)
24. Li JZ, Vawter MP, Walsh DM, Tomita H, Evans SJ, Choudary PV, Lopez JF, Avelar A, Shokoohi V, Chung T, Mesarwi O, Jones EG, Watson SJ, Akil H, Bunney WE, Jr, Myers RM (2004) Systematic changes in gene expression in postmortem human brains associated with tissue pH and terminal medical conditions. Hum Mol Genet 13, 609-616. (Pubitemid 38379850)
25. Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, Ku-bista M, Mueller R, Nolan T, Pfaffl MW, Shipley GL, Van-desompele J, Wittwer CT (2009) The MIQE guidelines: mini-muminformation for publication ofquantitative real-time PCR experiments. Clin Chem 55, 611-622.
26. Hellemans J, Mortier G, De Paepe A, Speleman F, Vandes-ompele J (2007) qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data. Genome Biol 8, R19.
27. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25, 402-408. (Pubitemid 34164012)
28. Zhang XM, Cai Y, Xiong K, Cai H, Luo XG, Feng JC, Clough RW, Struble RG, Patrylo PR, Yan XX (2009) Beta-secretase-1 elevation in transgenic mouse models of Alzheimer's disease is associated with synaptic/axonal pathology and amyloido-genesis: implications for neuritic plaque development. Eur J Neurosci 30, 2271-2283.
29. Stark AK, Pelvig DP, Jorgensen AM, Andersen BB, Pakken-berg B (2005) Measuring morphological and cellular changes in Alzheimer's dementia: a review emphasizing stereology. Curr Alzheimer Res 2, 449-481. (Pubitemid 41277759)
30. West MJ, Coleman PD, Flood DG, Troncoso JC (1994) Differences in the pattern of hippocampal neuronal loss in normal ageing and Alzheimer's disease. Lancet 344, 769-772. (Pubitemid 24283954)
31. Gomez-Isla T, Price JL, McKeel DW, Jr, Morris JC, Growdon JH, Hyman BT (1996) Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease. J Neurosci 16, 4491-4500. (Pubitemid 26243044)
32. SalehiA, Lucassen PJ, Pool CW, Gonatas NK, Ravid R, Swaab DF (1994) Decreased neuronal activity in the nucleus basalis of Meynert in Alzheimer's disease as suggested by the size of the Golgi apparatus. Neuroscience 59, 871-880. (Pubitemid 24149097)
33. Terry RD, Peck A, DeTeresa R, Schechter R, Horoupian DS (1981) Some morphometric aspects of the brain in senile dementia of the Alzheimer type. Ann Neurol 10, 184-192. (Pubitemid 11053105)
34. Simpson JE, Ince PG, Lace G, Forster G, Shaw PJ, Matthews F, Savva G, Brayne C, Wharton SB, MRC Cognitive Function and Ageing Neuropathology Study Group (2010) Astro-cyte phenotype in relation to Alzheimer-type pathology in the ageing brain. Neurobiol Aging 31, 578-590.
35. Rossner S, Lange-Dohna C, Zeitschel U, Perez-Polo JR (2005) Alzheimer's disease beta-secretase BACE1 is not a neuron-specific enzyme. J Neurochem 92, 226-234. (Pubitemid 40194014)
36. Sun X, He G, Qing H, Zhou W, Dobie F, Cai F, Staufenbiel M, Huang LE, Song W (2006) Hypoxia facilitates Alzheimer's disease pathogenesis by up-regulating BACE1 gene expression. Proc Natl Acad Sci U S A 103, 18727-18732. (Pubitemid 44913478)
37. Ye JT, Pi RB, Mao XX, Chen XH, Qin J, Xu SW, Liu PQ (2009) Alterations in mRNA expression of BACE1, cathepsin B, and glutaminyl cyclase in mice ischemic brain. Neuroreport 20, 1456-1460.
38. Wen Y, Yu WH, Maloney B, Bailey J, Ma J, Marie I, Maurin T, Wang L, Figueroa H, Herman M, Krishnamurthy P, Liu L, Planel E, Lau LF, Lahiri DK, Duff K (2008) Transcriptional regulation of beta-secretase by p25/cdk5 leads to enhanced amyloidogenic processing. Neuron 57, 680-690. (Pubitemid 351335351)
39. Giese KP, Ris L, Plattner F (2005) Is there a role of the cyclin-dependent kinase 5 activator p25in Alzheimer's disease? Neu-roreport 16, 1725-1730. (Pubitemid 41547036)
40. Fukumoto H, Rosene DL, Moss MB, Raju S, Hyman BT, Irizarry MC (2004) Beta-secretase activity increases with aging in human, monkey, and mouse brain. Am J Pathol 164, 719-725. (Pubitemid 38364685)